Igor Demin

Igor Demin

Auto-generated profile, based on publicly available information

Igor Demin

Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, Новосибирск

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2016 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
AKAlexander Karaskov
Alexander Karaskov
RSRavil Sharifulin
Ravil Sharifulin
SZSergey Zheleznev
Sergey Zheleznev
IDIgor Demin
Igor Demin
ELEvgeny Lenko
Evgeny Lenko
ABAlexander V. Bogachev-Prokophiev
Alexander V. Bogachev-Prokophiev
Although the Ross procedure provides excellent long-term survival and a high quality of life, only a limited number of centres perform it as an alternative to the standard aortic valve replacement in adults. In the present study, we evaluated our 16-year results of using the Ross procedure in adult patients. Between 1998 and 2014, 741 adult patients underwent the Ross procedure. The mean patient age was 47.4 ± 12.8 years (range, 18–67 years). The total root replacement technique was used in all patients. Right ventricular outflow tract (RVOT) reconstruction was performed with pulmonary allograft in 175 (23.6%) patients, with different types of xenografts in 561 (75.7%) and with polytetrafluoroethylene conduits in 5 (0.7%) patients. The early mortality rate was 3.0%. The mean follow-up duration was 5.8 ± 2.2 years. The survival rate at 10 years was 90.7% and was comparable with survival of an age- and sex-matched general population. The rate of freedom from autograft reoperations was 94.1 and 88.3% at 5 and 10 years, respectively. The aortic annulus dilatation was the only independent predictor of autograft failure. The 10-year freedom rates from reoperations for allograft, diepoxide- and glutaraldehyde-treated pericardial xenografts as well as porcine aortic root grafts were 100, 94.4, 82.7 and 80.6%, respectively. The use of xenografts and young patient age were associated with increased risk of RVOT conduit failure. The Ross operation provides long-term survival rates that are comparable with an age- and gender-matched general population. The dilated aortic annulus is a risk factor for late autograft valve insufficiency. A cryopreserved pulmonary homograft is the best option for RVOT reconstruction. Diepoxide-treated pericardial xenografts can be an alternative to allografts in elderly patients when an allograft is not available.

5 April 2018 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
RSRavil Sharifulin
Ravil Sharifulin
ABAlexander Bogachev-Prokophiev
Alexander Bogachev-Prokophiev
IDIgor Demin
Igor Demin
SZSergey Zheleznev
Sergey Zheleznev
APAlexey Pivkin
Alexey Pivkin
AKAlexander Karaskov
Alexander Karaskov
The type of conduit used for right ventricular outflow tract (RVOT) reconstruction during the Ross procedure remains problematic because of the limited availability of pulmonary allografts and the unsatisfactory long-term results associated with the use of xenografts. Polytetrafluoroethylene (PTFE) conduits have been proposed as an alternative. This study evaluated the results of RVOT reconstruction using a PTFE conduit during the Ross procedure. Between 2007 and 2015, 28 patients underwent RVOT reconstruction using PTFE conduits. The mean age of the patients was 35.9 ± 18.1 (range 4–58) years. The total root replacement technique was used in all patients. The mean PTFE conduit size was 25.3 ± 2.3 mm. The early mortality rate was 3.6% (1 patient). The mean follow-up duration was 48.5 ± 31.2 months; there were no late deaths. The transprosthetic gradients increased significantly over time. The conduit size was the only independent predictor of peak RVOT gradient progression (P = 0.02). None of the patients demonstrated significant RVOT regurgitation. One patient required an RVOT reoperation. The PTFE conduit demonstrates acceptable haemodynamic results at the mid-term follow-up and could be considered as an alternative substitute for RVOT reconstruction during the Ross procedure.

4 June 2018 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
RSRavil Sharifulin
Ravil Sharifulin
ABAlexander Bogachev-Prokophiev
Alexander Bogachev-Prokophiev
SZSergey Zheleznev
Sergey Zheleznev
IDIgor Demin
Igor Demin
APAlexey Pivkin
Alexey Pivkin
AKAlexander Karaskov
Alexander Karaskov

1 June 2016 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
AKAlexander Karaskov
Alexander Karaskov
ABAlexander V. Bogachev-Prokophiev
Alexander V. Bogachev-Prokophiev
RSRavil Sharifulin
Ravil Sharifulin
SZSergey Zheleznev
Sergey Zheleznev
IDIgor Demin
Igor Demin
IZIrina Zhuravleva
Irina Zhuravleva

1 January 2016 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
SZS. I. Zheleznev
S. I. Zheleznev
DDD. P. Demidov
D. P. Demidov
AAA. V. Afanasiev
A. V. Afanasiev
VNV. M. Nazarov
V. M. Nazarov
IDI. I. Demin
I. I. Demin
AКArray М. Караськов
Array М. Караськов
РАДИОЧАСТОТНАЯ ДЕНЕРВАЦИЯ ЛЕГОЧНОЙ АРТЕРИИ ПРИ ХИРУРГИЧЕСКОЙ КОРРЕКЦИИ ДИСПЛАСТИЧЕСКИХ ПОРОКОВ МИТРАЛЬНОГО КЛАПАНА С ВЫСОКОЙ ЛЕГОЧНОЙ ГИПЕРТЕНЗИЕЙ

1 January 2016
Verified
Journal Article
Closed access
AKAlexander Karaskov
Alexander Karaskov
ABA V Bogachev-Prokofiev
A V Bogachev-Prokofiev
RSRavil Sharifulin
Ravil Sharifulin
IDIgor Demin
Igor Demin
SZS I Zheleznev
S I Zheleznev
АПАлексей Пивкин
Алексей Пивкин